• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Exela Pharma Sciences is on Health Canada Inspection List

    HEALTH CANADA

    Enforcement Report - Week of September 17, 2025

    FDA

    Enforcement Report - Week of April 2, 2025

    FDA

    Enforcement Report - Week of November 29, 2023

    FDA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL Due to the Presence of Particulate Matter

    FDA

    Enforcement Report - Week of December 21, 2022

    FDA

    Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    FDA

    Enforcement Report - Week of November 2, 2022

    FDA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    FDA

    Enforcement Report - Week of January 19, 2022

    FDA

    Enforcement Report - Week of September 23, 2020

    FDA

    Enforcement Report - Week of May 30, 2018

    FDA

    Exela Issues Voluntary Recall of Ibuprofen Lysine Injection

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.